175 related articles for article (PubMed ID: 17043447)
1. Oncogenic hypophosphatemic osteomalacia associated with a nasal hemangiopericytoma.
Fuentealba C; Pinto D; Ballesteros F; Pacheco D; Boettiger O; Soto N; Fernandez W; Gabler F; Gonzales G; Reginato AJ
J Clin Rheumatol; 2003 Dec; 9(6):373-9. PubMed ID: 17043447
[TBL] [Abstract][Full Text] [Related]
2. Resolution of severe, adolescent-onset hypophosphatemic rickets following resection of an FGF-23-producing tumour of the distal ulna.
Ward LM; Rauch F; White KE; Filler G; Matzinger MA; Letts M; Travers R; Econs MJ; Glorieux FH
Bone; 2004 May; 34(5):905-11. PubMed ID: 15121023
[TBL] [Abstract][Full Text] [Related]
3. Metabolic studies in a patient with idiopathic hypophosphatemic osteomalacia.
Weiss M; Schechter P; Bab I; Mekhmandarov S; Bank H; Eisenstein Z
Isr J Med Sci; 1988 Jan; 24(1):46-50. PubMed ID: 3346150
[TBL] [Abstract][Full Text] [Related]
4. Oncogenic osteomalacia from nasal cavity giant cell tumor.
Battoo AJ; Salih S; Unnikrishnan AG; Jojo A; Bahadur S; Iyer S; Kuriakose MA
Head Neck; 2012 Mar; 34(3):454-7. PubMed ID: 22311466
[TBL] [Abstract][Full Text] [Related]
5. A case report of tumor-induced osteomalacia: eight year followed-up.
Ratanasuwan T; Chetsurakarn S; Ongphiphadhanakul B; Damrongkitchaiporn S
J Med Assoc Thai; 2008 Dec; 91(12):1900-2. PubMed ID: 19133527
[TBL] [Abstract][Full Text] [Related]
6. Tumor-induced hypophosphatemic osteomalacia associated with tertiary hyperparathyroidism: a case report.
Tartaglia F; Minisola S; Sgueglia M; Blasi S; Brunelli D; Degli Effetti E; Maturo A; Cola A; Custureri F; Campana FP
G Chir; 2006; 27(1-2):9-13. PubMed ID: 16608626
[TBL] [Abstract][Full Text] [Related]
7. Effects of tumor-induced osteomalacia on the bone mineralization process.
Nawrot-Wawrzyniak K; Varga F; Nader A; Roschger P; Sieghart S; Zwettler E; Roetzer KM; Lang S; Weinkamer R; Klaushofer K; Fratzl-Zelman N
Calcif Tissue Int; 2009 Apr; 84(4):313-23. PubMed ID: 19219382
[TBL] [Abstract][Full Text] [Related]
8. Tumor-induced osteomalacia: clinical and basic studies.
Shane E; Parisien M; Henderson JE; Dempster DW; Feldman F; Hardy MA; Tohme JF; Karaplis AC; Clemens TL
J Bone Miner Res; 1997 Sep; 12(9):1502-11. PubMed ID: 9286768
[TBL] [Abstract][Full Text] [Related]
9. [A case of adult onset hypophosphatemic vitamin D resistant osteomalacia].
Katagiri T; Suzuki T; Akiyama Y; Ishibashi T; Hara K; Oka H; Imai T; Kobayashi K; Kitagawa H; Ohno S
Ryumachi; 1992 Oct; 32(5):461-7; discussion 466-7. PubMed ID: 1440082
[TBL] [Abstract][Full Text] [Related]
10. Oncogenic vitamin D resistant hypophosphatemic osteomalacia (benign ossifying mesenchymal tumor of bone): case report.
Uchida H; Yokoyama S; Kashima K; Nakayama I; Shimizu K; Masumi S
Jpn J Clin Oncol; 1991 Jun; 21(3):218-26. PubMed ID: 1942553
[TBL] [Abstract][Full Text] [Related]
11. [Hypophosphatemic osteomalacia].
Bullmann C; Benker G; Rosien U; Delling G; Siggelkow H; Schulte HM
Med Klin (Munich); 2008 Sep; 103(9):671-5. PubMed ID: 18813890
[TBL] [Abstract][Full Text] [Related]
12. Osteomalacia due to 1alpha,25-dihydroxycholecalciferol deficiency. Association with a giant cell tumor of bone.
Drezner MK; Feinglos MN
J Clin Invest; 1977 Nov; 60(5):1046-53. PubMed ID: 908749
[TBL] [Abstract][Full Text] [Related]
13. Sinonasal hemangiopericytoma caused hypophosphatemic osteomalacia: A case report.
Li J; Huang Y; Yang F; Zhang Q; Chen D; Wang Q
Medicine (Baltimore); 2018 Dec; 97(52):e13849. PubMed ID: 30593185
[TBL] [Abstract][Full Text] [Related]
14. Bone densitometry in a patient with hypophosphatemic osteomalacia.
Negri AL; Bogado CE; Zanchetta JR
J Bone Miner Metab; 2004; 22(5):514-7. PubMed ID: 15316875
[TBL] [Abstract][Full Text] [Related]
15. Tumor-induced osteomalacia originating from the temporal bone: a case report.
Kobayashi K; Nakao K; Kawai K; Ito K; Hukumoto S; Asakage T; Oota S; Motoi R
Head Neck; 2011 Jul; 33(7):1072-5. PubMed ID: 20146335
[TBL] [Abstract][Full Text] [Related]
16. Hypophosphatemic Osteomalacia in a Young Adult.
Paramba F; Silas M; Masoodi N; Benjamin S; Palaki JA
Cureus; 2021 Mar; 13(3):e13697. PubMed ID: 33833917
[TBL] [Abstract][Full Text] [Related]
17. Renal phosphate loss in hereditary and acquired disorders of bone mineralization.
Bielesz B; Klaushofer K; Oberbauer R
Bone; 2004 Dec; 35(6):1229-39. PubMed ID: 15589204
[TBL] [Abstract][Full Text] [Related]
18. [Hypophosphatemic oncogenic osteomalacia].
Mátyus J; Szebenyi B; Rédl P; Mikita J; Gáspár L; Haris A; Radó J; Kakuk G
Orv Hetil; 2000 Dec; 141(51):2785-8. PubMed ID: 11196239
[TBL] [Abstract][Full Text] [Related]
19. Hypophosphatemia induced by intravenous administration of saccharated ferric oxide: another form of FGF23-related hypophosphatemia.
Shimizu Y; Tada Y; Yamauchi M; Okamoto T; Suzuki H; Ito N; Fukumoto S; Sugimoto T; Fujita T
Bone; 2009 Oct; 45(4):814-6. PubMed ID: 19555782
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic utility of magnetic resonance imaging skeletal survey in a patient with oncogenic osteomalacia.
Fukumoto S; Takeuchi Y; Nagano A; Fujita T
Bone; 1999 Sep; 25(3):375-7. PubMed ID: 10495143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]